Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for ...
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings ...
World-renowned colorectal surgeon Steven Wexner, MD, has joined MedStar Health as physician executive director and system chief of Colorectal ...
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
NEW YORK – Azalea Therapeutics launched on Tuesday, having raised $82 million in seed and Series A financing to develop in vivo genetic medicines for cancer and autoimmune conditions using its ...
Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...
The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...
Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback